Media Database
>
Erin Michael

Erin Michael

Editorial Features Manager & Online Content Editor at Healio

Contact this person
Email address
e*****@*******.comGet email address
Influence score
54
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine
  • Life

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

healio.com

VIDEO: Immunotherapy ‘main focus in the field’ of acute lymphoblastic leukemia

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.Molina, who is an associate staff clinician in the leukemia and myeloid disorders division at Cleveland Clinic, explained that “a lot of the talks were kind of focused on immunotherapy, as it’s the main focus in
healio.com

VIDEO: Updates in immune, cellular therapies in acute myeloid leukemia

In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting. Daver, professor and director of the Leukemia Research Alliance Program in the department of leukemia at The University of Texas MD Anderson Cancer Center, said that Marion Subklewe, MD, of Ludwig-Maximilians-University
healio.com

VIDEO: PERSEUS trial results 'practice-changing' for newly diagnose...

Healio spoke with Chakra Chaulagain, MD, about phase 3 PERSEUS trial results presented at ASH 2023.
healio.com

VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sc...

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.The ongoing phase 2 study is assessing bexotegrast in patients with primary sclerosing cholangitis and suspected liver fibrosis, and evaluating its safety, tolerability and
healio.com

Patients with MASLD lost less weight after bariatric surgery, study...

BOSTON — Patients with metabolic dysfunction-associated steatotic liver disease who underwent bariatric surgery lost less weight over 5 years than those without MASLD, according to research presented at The Liver Meeting.“Individuals with MASLD at baseline lost less total weight,” Monica Tincopa, MD, MS, a gastroenterologist, transplant hepatologist and assistant professor of
healio.com

Ovarian cancer research at ESMO Congress explores chemotherapy-free...

MADRID — This year’s ESMO Congress included research updates that provide valuable data on chemotherapy-free treatment options being explored in recurrent ovarian cancer. Kosei Hasegawa, MD, PhD, associate professor at Saitama Medical University International Medical Center, said during a discussion on data presented from two trials — phase 3 results from NRG-GY004 and
healio.com

VIDEO: Primary biliary cholangitis treatments poised to be clinical...

BOSTON — Healio spoke with James L. Boyer, MD, about phase 3 findings from the RESPONSE trial and the ELATIVE trial and presented at The Liver Meeting.
healio.com

High ultra-processed food intake linked to increased MASLD risk in ...

Increased consumption of ultra-processed foods was associated with higher odds of developing metabolic dysfunction-associated steatotic liver disease in both adolescents and adults, according to research presented at The Liver Meeting. “The consumption of ultra-processed foods (UPF) has increased dramatically over the past two decades and has been associated with obesity, type 2 diabetes,
healio.com

Q&A: Supportive care in young adults with leukemia

Healio spoke with Nikki Yuill, LCSW, and Michelle Rajotte, LMSW, the director and associate director of The Leukemia & Lymphoma Society’s Information Resource Center, about the importance of supportive care in young adults with leukemia.
healio.com

VIDEO: Sitravatinib plus nivolumab does not offer OS benefit over ....

Healio spoke with Hossein Borghaei, DO, MS, about results from the SAPPHIRE trial presented at this year’s ESMO Congress.“Unfortunately, we realized that for our patients who are being treated upfront with a combination of chemotherapy and immunotherapy, at the time of disease progression, their options are rather limited,” Borghaei, chief of thoracic medical oncology, professor
healio.com

VIDEO: Surgery 'not for everyone' with mesothelioma, not linked to ...

Healio spoke with Melina Elpi Marmarelis, MD, about key takeaways from the MARS 2 trial presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
healio.com

VIDEO: Osimertinib after chemoradiation may benefit EGFR-mutated ad...

Melina Elpi Marmarelis, MD, discussed research on the use of osimertinib versus durvalumab following chemoradiation in patients with stage III EGFR-mutated NSCLC.